Baricitinib - Wikipedia
WEBBaricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. [7][8][9][10] It acts as an inhibitor of janus kinase …
Baricitinib: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBAug 19, 2024 · Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes baricitinib side effects, interactions, and indications.
Olumiant (baricitinib) dosing, indications, interactions, adverse ...
WEBRheumatoid Arthritis. Indicated for adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist...
Baricitinib (Oral Route) Description and Brand Names - Mayo Clinic
WEBOct 1, 2024 · Baricitinib is a Janus kinase (JAK) inhibitor that works on the immune system. This medicine is available only with your doctor's prescription for rheumatoid arthritis. This medicine is to be given only by or under the immediate supervision of your doctor for COVID-19.
What is Olumiant® for RA & How it Works | Olumiant® (baricitinib)
WEBDiscover how Olumiant® (baricitinib) works as a Janus kinase (JAK) inhibitor. Learn more about talking to your doctor and finding a rheumatologist.
Baricitinib - StatPearls - NCBI Bookshelf
WEBJan 10, 2024 · Baricitinib is a disease-modifying antirheumatic drug (DMARD) indicated for rheumatoid arthritis when conventional DMARDs prove inadequate.
Baricitinib: MedlinePlus Drug Information
WEBBaricitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who have not responded well to one or more tumor …
Efficacy of baricitinib in patients with moderate-to-severe …
WEBJan 22, 2024 · Baricitinib, an oral selective Janus kinase 1/2 inhibitor, is approved for the treatment of adults with moderately-to-severely active RA, moderate-to-severe atopic dermatitis, severe alopecia areata and hospitalized patients with coronavirus disease 2019 .
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
WEBDec 11, 2020 · Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving...
Baricitinib: Uses & Side Effects - Cleveland Clinic
WEBBaricitinib is a medication that treats rheumatoid arthritis. RA is a type of arthritis where your immune system attacks the tissue lining the joints on both sides of your body. This medication can also treat severe hair loss and COVID-19 by helping your immune system.